Showing results (31-40 of 350) with videos related to
Sort By:
Pageof 35
Trends in Neurosciences|October 29, 2000
Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonismT N Chase, J D OhArchives of Neurology|April 1, 1980
Bromocriptine and CF 25-397 in the treatment of tardive dyskinesiaC A Tamminga, T N ChaseNeuroscience Letters|December 19, 1988
Dextromethorphan does not protect against quinolinic acid neurotoxicity in rat striatumT M Engber, T N ChaseEuropean Journal of Pharmacology|March 15, 1988
Behavioral effects of chronic exposure to selective D-1 and D-2 dopamine receptor agonistsA R Braun, T N ChaseAnnals of Neurology|September 1, 1978
Huntington's disease: treatment with muscimol, a GABA-mimetic drugI Shoulson, D Goldblatt, M Charlton, et al.Annals of Neurology|October 1, 1988
Cerebrospinal fluid levels of quinolinic acid in Huntington's disease and schizophreniaR Schwarcz, C A Tamminga, R Kurlan, et al.Neurology|July 1, 1986
Double-blind assessment of potential pergolide-induced cardiotoxicityR Kurlan, C Miller, R Knapp, et al.Neuroscience Letters|October 28, 1991
Heterogeneous dopamine receptor changes in early and late Huntington's diseaseE K Richfield, C F O'Brien, T Eskin, et al.Neurology|August 1, 1980
Demonstration of CSF gamma-globulin banding in presenile dementiaA Williams, N Papadopoulos, T N ChaseArchives of Neurology|April 1, 1979
Endocrinologic regulation of carbohydrate metabolism. Amyotrophic lateral sclerosis and Parkinsonism-dementia on GuamY Nagano, T Tsubaki, T N ChasePageof 35